Using self-report measures in neurobehavioural toxicology: can they be trusted?

Neurotoxicology
Ann Williamson

Abstract

Questionnaires are one of the most common methodologies used in research on neurobehavioural effects in occupational and environmental health, most commonly for gathering information on demographic characteristics, psychological or neurological symptoms, mood state, or exposure to hazards. Questionnaires are self-report measures, so by definition are subjective, although their degree of subjectivity depends on the phenomenon they are measuring. For some phenomena questionnaires are used because they are convenient but the information can be obtained from other sources. For other phenomena questionnaire or self-report is the only way of obtaining the information, for example, feelings and experiences, mood or emotions. Questionnaires are essential tools in psychological and neurobehavioural research as they can tap into aspects of nervous system function that cannot be readily measured in other ways. Despite the obvious need for self-report measures, there are a number of serious issues that threaten their validity as effective indicators of neurobehavioural function. This paper considers the implications of some of the major problems with self-report measures, focusing particularly on current approaches to measurement of sympto...Continue Reading

References

Sep 1, 1990·The British Journal of Medical Psychology·C Cooper, C McConville
Oct 1, 1990·Journal of Clinical and Experimental Neuropsychology·K A Hawkins
Feb 1, 1989·Scandinavian Journal of Work, Environment & Health·L Piikivi, H Hänninen
Feb 1, 1984·Scandinavian Journal of Work, Environment & Health·P MantereR Luukkonen
May 1, 1997·Occupational and Environmental Medicine·I LundbergC Hogstedt
Jan 1, 1997·Environmental Research·D ChouanièreR Gilioli
Jan 1, 1997·Environmental Research·E KiesswetterA Seeber
Jan 30, 1999·Journal of Occupational and Environmental Medicine·K N LindgrenM L Bleecker
Jul 19, 2001·Journal of the International Neuropsychological Society : JINS·M C SalinskyL M Binder
Apr 6, 2002·Occupational and Environmental Medicine·M ZupanicA Seeber
May 23, 2002·Biological Psychiatry·Marie Pascale SassineH Kenneth Hudnell
Mar 28, 2003·Occupational and Environmental Medicine·T M FarahatW K Anger
Apr 30, 2003·Scandinavian Journal of Work, Environment & Health·Christoph van ThrielAndreas Seeber
Jul 3, 2003·International Archives of Occupational and Environmental Health·M BuchtaS Letzel
Aug 6, 2003·Neurotoxicology·Isabelle RouchDominique Chouaniere
Aug 16, 2003·BMJ : British Medical Journal·Sonja Hunt, Raj Bhopal
Sep 23, 2003·American Journal of Industrial Medicine·Nancy FiedlerMichael Gochfeld
Nov 15, 2003·Environmental Research·John S ReifW Kent Anger
Nov 25, 2003·International Journal of Hygiene and Environmental Health·Rosemarie M BowlerHarry A Roels
Dec 4, 2003·Journal of Occupational Health·Srmena KrstevRadmila Banićević
Mar 17, 2004·International Archives of Occupational and Environmental Health·Rita Bast-PettersenYngvar Thomassen
Apr 8, 2004·Environmental Research·Steven G InserraMary C White
Apr 13, 2004·Journal of Occupational and Environmental Medicine·Ignatius Tak-Sun YuTze Wai Wong
Sep 4, 2004·Environmental Health Perspectives·Gaku IchiharaYasuhiro Takeuchi
Nov 9, 2004·Scandinavian Journal of Work, Environment & Health·Edgar DelgadoCatharina Wesseling
Nov 20, 2004·American Journal of Industrial Medicine·Ari KaukiainenMarkku Sainio
May 18, 2005·American Journal of Industrial Medicine·David AtrubinT L Bean
Jul 28, 2005·Occupational and Environmental Medicine·F Forastiere, C Galassi
Apr 1, 2004·Expert Review of Pharmacoeconomics & Outcomes Research·Jordana K Schmier, Michael T Halpern
May 1, 2005·Environmental Toxicology and Pharmacology·Andreas SeeberMichaela Zupanic
May 1, 2005·Environmental Toxicology and Pharmacology·Axel MuttrayStephan Letzel
May 1, 2005·Environmental Toxicology and Pharmacology·Mark Buchta AS Letzel A
May 1, 2005·Environmental Toxicology and Pharmacology·Maryse BouchardMary Baldwin
May 1, 2005·Environmental Toxicology and Pharmacology·Lu RongzhuJames J Collins

❮ Previous
Next ❯

Citations

Jul 8, 2008·International Archives of Occupational and Environmental Health·Ari KaukiainenMarkku Sainio
Jan 19, 2012·Brain Structure & Function·Aisling O'Neill, Thomas Frodl
Feb 22, 2012·Deviant Behavior·Scott MenardHerbert C Covey
Jan 13, 2010·International Clinical Psychopharmacology·Samuel Suk-Hyun HwangYong Sik Kim
May 9, 2012·Neurotoxicology·Heidi FuruAri Kaukiainen
Dec 8, 2009·Neurotoxicology·Ari KaukiainenMarkku Sainio
Jun 20, 2008·Neurotoxicology·Maryse BouchardMichel Panisset
Jan 28, 2014·Neurotoxicology·Heidi FuruAri Kaukiainen
Sep 5, 2015·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·L E Schrieff-ElsonA A Figaji
Nov 5, 2016·Neurotoxicology·Samuel KeerJeroen Douwes
Mar 30, 2018·International Archives of Occupational and Environmental Health·Heidi FuruAri Kaukiainen
Mar 23, 2017·Progress in Neuro-psychopharmacology & Biological Psychiatry·Scott J Moeller, Martin P Paulus

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.